FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/04/008441 [Registered on: 28/04/2017] Trial Registered Prospectively
Last Modified On: 27/04/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Medical Device
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   to evaluate the effect of yashtimadhu amlaki churna in hairfall and to compare the mode of administration of yashtimadhukadi tail on hairfall through scalp and through nasal route. 
Scientific Title of Study   A Comparative Clinical Trial To Evaluate The Efficacy Of Nasya And Shiro-Abhayanga Of Yashtimadhukadi Tailam With Oral Administration Of Yashtimadhu-Amlaki Churna In Khalitya W.S.R. To Hairfall 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr A Rama Murthy 
Designation  Assistant Professor 
Affiliation  National Institute of Ayurveda 
Address  Dr A. Rama Murthy, Assistant Professor, Dept of Dravya Guna Vigyana, National Institute of Ayurveda, Jaipur, 302002

Jaipur
RAJASTHAN
302002
India 
Phone  9314513659  
Fax    
Email  armurthy_2005@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Parul Anand 
Designation  M.D Scholar 
Affiliation  National Institute of Ayurveda 
Address  Parul Anand, M.D Scholar, Dept of Dravya Guna Vigyana, National Institute of Ayurveda, Jaipur, 302002
National Institute of Ayurveda, Jaipur, 302002
Jaipur
RAJASTHAN
302002
India 
Phone  9086081993  
Fax    
Email  anand.parul.mailbox@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Parul Anand 
Designation  M.D Scholar 
Affiliation  National Institute of Ayurveda 
Address  Parul Anand, M.D Scholar, Dept of Dravya Guna Vigyana, National Institute of Ayurveda, Jaipur, 302002
National Institute of Ayurveda, Jaipur, 302002
Jaipur
RAJASTHAN
302002
India 
Phone  9086081993  
Fax    
Email  anand.parul.mailbox@gmail.com  
 
Source of Monetary or Material Support  
National Istitute of Ayurveda, near joravar singh gate amber road Jaipur Rajasthan 302002 
 
Primary Sponsor  
Name  National Institute of Ayurveda Jaipur 
Address  National Institute of Ayurveda Jaipur 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Parul Anand  Arogyashala, National Institute of Ayurveda Jaipur  OPD no 25 Dept of Dravyaguna vigyana
Jaipur
RAJASTHAN 
09086081993

anand.parul.mailbox@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Comittee National institute of Ayurveda Jaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Khalitya (Hairfall) ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  nasya with oral administration of yashtimadhu amlaki churna.  Marsha nasya will be done using yashtimadhukadi tail for a period of 7 days. Yashtimadhu churna 4 gms and amlaki churna 6 gms will be given in two divided doses for a period of 60 days. 
Intervention  Shiro Abhyanga with oral administration of yashtimadhu amlaki churna.  Shiro abhyanga will be done using yashtimadhukadi tail for a period of 30 days. Yashtimadhu churna 4 gms and amlaki churna 6 gms will be given orally in two divided doses for a period of 60 days. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1)Patients who have classical signs and symptoms of khalitya since one month or more.
2)Patients within age group of 20 to 40 years of either sex.
 
 
ExclusionCriteria 
Details  1)Patients below 20 years and above 40 years.
2)Patients who have diseases like Alopecia totalis, Tinea capitis, folliculisis devaculans and in Ayurvediya terms patients of Arunshika, Indralupta.
3)Patient suffering from any systemic diseases.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
It is expected that trial drug will exert a significant action over hairfall with other associated symptoms.  15 months 
 
Secondary Outcome  
Outcome  TimePoints 
Significant reduction in the hairfall (through the procedure and the oral drug) will increase quality of life, self conidence and self esteem of the person with total gain of mental, physical and spiritual health.  60 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   15/05/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   A comparative clinical trial to evaluate the efficacy of yashtimadhu amlaki churna in khalitya w.s.r to hairfall will be conducted. 60 patients will be selected randomly from Arogyashala OPD & IPD, National Institute of  Ayurveda, Jaipur which will be well diagnosed having Khalitya (hairfall) as per the signs and symptoms described in Ayurvedic classical text. Duration of administration of oral drug will be 60 days. Yashtimadhu churna 4 gms and amlaki churna 6 gms will be given in two divided doses per day to the patients. All the participants will be divided into two groups. Group A will be given the above mentioned oral drug along with the nasya of yashtimadhukadi tail for 7 days. Group B will be given the above mentioned oral drug along with the shiro abhyanga of yashtimadhukadi tail for 30 days. Follow up will be done at 15, 30, 45 and 60 days after the completion of the trial. Written informed consent will be obtained. No economical aid will be given to the patient during the trial. ADR, if any will be recorded in the prescribed format and reported to RPVC, NIA, Jaipur. ADR, if any will be managed and / or referred suitably. 
Close